Guidelines on CVD during Pregnancy (TF17) - Task Force Members and Additional Contributors Expert Relationship Type of relationship with industry Financial declaration with Industry Blomstrom-Lundqvist Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. Carina - Medtronic : Pacemaker B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Atricure : AF ablation Borghi Claudio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Menarini International : ACE-inhibitors - Boheringer Ingelheim : Antihypertensive drugs - Recordati International : Antihypertensive drugs - Novartis : Antihypertensive, Heart Failure D - Research funding (departmental or institutional). - Barilla Food Company : Lactotripeptides Cifkova Renata Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boehringer-Ingelheim : cardiovascular - Daiichi Sankyo : cardiovascular - MSD-SP, Boehringer Ingelheim, Bayer : cardiovascular B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : cardiovascular - Novartis : cardiovascular D - Research funding (departmental or institutional). - Krka Czech Republic : cardiovascular - Servier Czech Republic : cardiovascular Ferreira J Rafael No Foidart Jean-Michel No Gibbs Simon Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - GSK - consulting or lecture fees : Pulmonary hypertension: ambrisentan, Flolan - Actelion : Pulmonary hypertension: bosentan - Pfizer - consulting or lecture fees : Pulmonary hypertension: Sildenafil - Lilly : Pulmonary hypertension: Tadalafil Guidelines on CVD during Pregnancy (TF17) - Task Force Members and Additional Contributors Expert Relationship Type of relationship with industry Financial declaration with Industry Gibbs Simon Yes - United Therapeutics : Pulmonary hypertension: Treprostinil - Bayer : Ventavis D - Research funding (departmental or institutional). - United Therapeutics : Pulmonary hypertension: treprostinil Gohlke-Baerwolf Christa No Gorenek Bulent No Iung Bernard Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : benfluorex - Boehringer Ingelheim : dabigatran - Edwards Lifesciences : heart valve prosthesis - St. Jude Medical : heart valve prosthesis - Abbott : Mitraclip - Sanofi Aventis : None (educational program) - Bayer : rivaroxaban Kirby Michael Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Menarini : cardiology - Eli Lilly : diabetes and erectile dysfunction - Pfizer : erectile dysfunction - Bayer : erectile dysfunction and testosterone - Takeda : hypertension, diabetes - Astra Zeneca : lipids - Merck, Schering Plough : lipids - Wiley Blackwell : men's health - Boehringer Ingelheim - : Thromboprophylaxis C - Receipt of royalties for intellectual property. - Wiley Blackwell : Men's Health and journal work Guidelines on CVD during Pregnancy (TF17) - Task Force Members and Additional Contributors Expert Relationship Type of relationship with industry Financial declaration with Industry Kirby Michael Yes D - Research funding (departmental or institutional). - Merck Sharp & Dohme : lipids - Boehringer-Ingelheim : lower urinary tract symptoms - Bayer Healthcare : testosterone Maas Angela Helena No Elisabeth Maria Mahaffey Kenneth W Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Amgen : Cardiovascular - Astra Zeneca : Cardiovascular - Bayer : Cardiovascular - BMS : Cardiovascular - Boehringer-Ingelheim : Cardiovascular - Eli Lilly : Cardiovascular - Novartis : Cardiovascular - Sanofi Aventis : Cardiovascular - Johnson & Johnson : Cardiovascular - Genentech : Cardiovascular - Glaxo Smith Kline : Cardiovascular - Elsevier (AHA) : Cardiovascular - WebMD : Cardiovascular D - Research funding (departmental or institutional). - Amgen : Cardiovascular - Astra Zeneca : Cardiovascular - Bayer : Cardiovascular - Boehringer-Ingelheim : Cardiovascular - Edwards Lifesciences : Cardiovascular Guidelines on CVD during Pregnancy (TF17) - Task Force Members and Additional Contributors Expert Relationship Type of relationship with industry Financial declaration with Industry Mahaffey Kenneth W Yes - Eli Lilly : Cardiovascular - Medtronic : Cardiovascular - Merck : Cardiovascular - Novartis : Cardiovascular - The Medicines Company : Cardiovascular - Regado : Cardiovascular - Johnson & Johnson : Cardiovascular - Schering-Plough : Cardiovascular - Abbott Vascular : Cardiovascular - Portola Pharmaceuticals : Cardiovascular - Bristol Myers Squibb : Cardiovascular - Amylin : Cardiovascular - Cardiokinetix : Cardiovascular - Cordis : Cardiovascular - Guidant : Cardiovascular - Innocoll : Cardiovascular - Luitpold : Cardiovascular - Pozen : Cardiovascular Morais Joao Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer - speaker fees; advisory board fees (rivaroxaban) : anticoagulants - Merck, Schering Plough : antiplatelets - Astra Zeneca - speakers fees; advisory board fees (ticagrelor) : antiplatelets - Merck Sharp & Dohme : atherosclerosis, lipids - JaBA Recordati : hypertension Guidelines on CVD during Pregnancy (TF17) - Task Force Members and Additional Contributors Expert Relationship Type of relationship with industry Financial declaration with Industry Nihoyannopoulos Petros Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bracco Pharmaceutical : Sonovue Pieper Els Petronella G No Presbitero Patrizia No Regitz-Zagrosek Vera Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Berlin Chemie AG : ARB B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Wilmar Schwabe : phytotherapeutics Roos-Hesselink Jolien W No Schaufelberger Maria Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fees : education in heart failure for GPs and nurses B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Orion : education in heart failure for GPs and patients Seeland Ute No Torracca Lucia Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - St Jude Medical : valves, rings, device for Afib ablation Guidelines on CVD during Pregnancy (TF17) - Document Reviewers Expert Relationship Type of relationship with industry Financial declaration with Industry Al-Attar Nawwar No Alonso Garcia Maria No Angeles Antoniou Anna Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Antiarrythmics-Dronedarone B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boehringer-Ingelheim (payment pending) : Antithrombotics - AF Baumgartner Helmut Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Actelion : Bosentan for PAH treatment in congenital heart disease - AGA : Devices for catheter treatment of congenital heart defects B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Edwards Lifesciences : transcatheter valve implantation Coman Ioan Mircea Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : anticoagulants - Astra Zeneca - speaker fees : dyslipidemia - Boeringer : dyslipidemia - Amgen : eritropoetin analogues - Novartis : PHT treatment - Actelion : PHT treatment - Lung Rx : PHT treatment - Eli Lilly : prasugrel B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi-Sankyo : anticoagulants - Amgen Inc : eritropoetin analogues - Lung Rx : PHT trt. - Eli Lilly : prasugrel C - Receipt of royalties for intellectual property. - Pfizer : dyslipidemia Guidelines on CVD during Pregnancy (TF17) - Document Reviewers Expert Relationship Type of relationship with industry Financial declaration with Industry Coman Ioan Mircea Yes - Sanatatea Media group : dyslipidemia Deaton M Christi Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - St Jude Ltd : Cath lab - speaker X 1 - Daiichi Sankyo : consultant for patient adherence 2009-10 - Eli Lilly : consultant for patient adherence 2009-10 D - Research funding (departmental or institutional). - Novo Nordisk : medicines for diabetes Elkayam Uri Yes D - Research funding (departmental or institutional). - Amgen : Heart failure